|
Pharmaceutical companies in US and Europe are facing pressing challenges in increasing costs for clinical drug development, tougher regulatory demands, difficulty in patient recruitment, longer drug development timelines and competition with generic companies.
This has led many companies to move to Asia to leverage on the region’s lower cost of clinical drug development, laissez-fair regulations, and high patient pool. However, amidst the positive factors, western companies that would like to gain a foothold in the Asian market also face other challenges, such as finding the right local partners, maneuvering through the local regulatory landscape effectively, and finding accredited clinical sites.
Applying outdated strategies will only delay your drug development process and lead to greater expenses. Accelerate your clinical drug development process in Asia with the right strategic approaches now. At World Pharma Trials Asia 2010, you will get to learn the best operational strategies from government regulators and industry experts from top pharmas, biotechs and CROs in fast-tracking clinical drug development in Asia!
This is where you will get to uncover:
- Trends, opportunities & challenges in conducting clinical trials in Asia
- Latest regulatory developments & strategies for compliance
- Strategies in conducting clinical studies in different therapeutic areas
- Site selection and patient recruitment strategies in Asia
- Clinical supply chain strategies
- Clinical trial safety & ethics
- Global strategies for successful clinical drug development in Asia
|
| Confirmed speakers: |
Mingyang Liao
Director
National Centre for New Drug Safety Evaluation, China |
Ahn Mee Ryung
Deputy Director
KFDA, Korea
|
A B Ramteke
Joint Drugs Controller of India
CDSCO |
Selvaraja Seerangam
Director
National Pharmaceutical Control Bureau Ministry of Health, Malaysia
|
Songlin Xue
Senior Vice President & Global Head of Pharmacovigilance
Takeda, USA
|
Alain Bouckenooghe
Associate Vice President and Head of Clinical R&D Asia
Sanofi Pasteur, Singapore
|
Xiaoxiang Chen
Vice President
Clinical Operations Boehringer-ingelheim, China
|
|